SCHEMBL3969744

SCHEMBL3969744

COc1c(C=CC(=O)c2ccc(O)cc2)cc(C)c(C(=O)O)c1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 4/20 0.55
CTSB P07858 4/20 0.55
CAPN1 P07384 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
MAOB P27338 1/20 0.52
DPP4 P27487 3/20 0.51
PTPN1 P18031 2/20 0.50
CHRNA7 P36544 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
MAPT P10636 2/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
P4HB P07237 1/20 0.48
CALM1 P0DP23 1/20 0.48
RAB9A P51151 1/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
F3 P13726 1/20 0.48
XDH P47989 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3969812 0.88 CAPN1 (0.45) CTSLCTSBCAPN1TDP1MAOB
SCHEMBL7191606 0.87 CTSL (0.58) CTSLCTSBCAPN1TDP1MAOB
SCHEMBL7191609 0.87 CTSL (0.58) CTSLCTSBCAPN1TDP1MAOB
SCHEMBL498781 0.87 PPARG (0.51) CA1CA2MAPTABCG2RAB9A
SCHEMBL498960 0.84 NR1H4 (0.57) CTSLTDP1PTPN1CHRNA7MAPT
SCHEMBL3970906 0.82 KRAS (0.51) MAOBDPP4PTPN1MAPTABCG2
SCHEMBL498101 0.81 MAPT (0.59) MAOBCHRNA7MAPTABCG2RAB9A
SCHEMBL7194836 0.79 PTPN1 (0.65) CTSLCTSBCAPN1TDP1MAOB
SCHEMBL7194832 0.79 PTPN1 (0.65) CTSLCTSBCAPN1TDP1MAOB
SCHEMBL3972097 0.78 LMNA (0.46) CA1CA2MAPTABCG2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566737-B2 Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2009-07-28 US claimed
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2007-02-08 US claimed
US-7566737-B2 Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2009-07-28 US disclosed
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients PSEN1, BACE1, PSEN2 CTSL 2649/4885CTSB 734/4885CAPN1 2075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.